- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04283279
Exercise to Improve Balance in Older Adults With Hearing Impairment - a Proof-of-concept Study
Balance and Mobility in Older Adults With Hearing Impairment
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Study design:
This is an experimental (exercise) study with follow-ups three and twelve months after exercise completion.
Participants:
Participants will be recruited from two instances:
- "Praksisnett", which is a collaboration between GPs and researchers in Bergen, Norway, where GPs recruit potential participants to research projects.
- The Ear, Nose, Throat department at Haukeland University Hospital (Bergen), who provide service to older adults with hearing impairment. The aim is to include 60 patients into three intervention arms: i) virtual reality exercises, ii) vestibular rehabilitation exercises and usual care
Intervention arms:
- Virtual reality exercises: Participants will exercise in virtual environments twice weekly. The choice of environments/tasks will be individualized, and progress from sitting/standing exercises, to doing exercises while walking on a treadmill. The aim is to perform cognitive and motor tasks simultanously.
- Vestibular rehabilitation exercises: This is an exercise approach that has been used in clinical groups, such as patients with vestibular disorders and traumatic brain injury. The aim is to perform movements/exercises where the participant is exposed gradually to movements that may be provocative for the vestibular system.
The exercises will be done in a movement lab at Western Norway University of Applied Sciences. Participants will be randomised to either of the three intervention arms using a computerized procedure. Neither participants, testers or deliverers of the intervention will be blinded. Testers and intervention deliverers will be physiotherapists, students enrolled in a master program in clinical physiotherapy and bachelor students in physiotherapy.
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Hearing threshold above 30 dB
Exclusion Criteria:
- Inability to give informed consent,
- Inability to speak Scandinavian languages or English
- Diseases with severe motor impairments (such as mb Parkinsons)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Virtual reality exercise
20 participants will be randomised to this arm
|
Participants will do exercises in a virtual environment, solving tasks that require cognitive efforts and motor/balance efforts.
The virtual environment/tasks will be delivered through a head-mounted display ("goggles").
Difficulty will progress from standing/sitting, to walking on a treadmill.
The environments that will be used will be both over-the-counter environments, as well as in-house designed environments.
|
|
Expérimental: Vestibular rehabilitation exercise
20 participants will be randomised to this arm
|
Vestibular rehabilitation exercises focus on head and eyes movements, as well as whole-body movements.
The aim is to facilitate the use of other sensory organs than the vestibular organs, which will also be relevant to persons who are not receiving sufficient sensory information from the auditory system.
The exercises will progress as tolerated, under careful supervision of trained therapists.
|
|
Autre: Control
20 participants will be randomised to this arm
|
Participants will not be randomised to either of the exercise interventions, but will be adviced to stay active
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Short physical performance battery
Délai: Measured as change from baseline/before intervention, to after intervention (six weeks after baseline), to three months after intervention and to 12 months after intervention
|
Test of balance and mobility, with three tasks (walking, standing balance, sit-to-stand), scores from 0-12.
|
Measured as change from baseline/before intervention, to after intervention (six weeks after baseline), to three months after intervention and to 12 months after intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Standing balance - posturography
Délai: Measured as change from baseline/before intervention, to after intervention (six weeks after baseline), to three months after intervention and to 12 months after intervention
|
Body sway measured on a balance platform, with eyes open/closed and on a firm/compliant surface
|
Measured as change from baseline/before intervention, to after intervention (six weeks after baseline), to three months after intervention and to 12 months after intervention
|
|
Walking balance
Délai: Measured as change from baseline/before intervention, to after intervention (six weeks after baseline), to three months after intervention and to 12 months after intervention
|
Participants will walk across an electronic walkway that registers steps, for analysis of gait steadiness
|
Measured as change from baseline/before intervention, to after intervention (six weeks after baseline), to three months after intervention and to 12 months after intervention
|
|
The World Health Organisation Disability Assessment Schedule (WHODAS)
Délai: Measured as change from baseline/before intervention, to after intervention (six weeks after baseline), to three months after intervention and to 12 months after intervention
|
Questionnaire that registers disability across several domains.
Possible score range is 0-144, where lower values indicate less disability
|
Measured as change from baseline/before intervention, to after intervention (six weeks after baseline), to three months after intervention and to 12 months after intervention
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Activity monitoring
Délai: Measured as change from baseline/before intervention to after intervention (6 weeks after baseline)
|
Participants will wear sensors over 4 days, registering activity in their own environments
|
Measured as change from baseline/before intervention to after intervention (6 weeks after baseline)
|
|
Dizziness Handicap Inventory
Délai: Measured at baseline/before intervention and after intervention (6 weeks after baseline)
|
25 item-questionnaire that registers limitations due to dizziness.
Possible scores range from 0-100, and higher scores indicate more dizziness-related handicap.
|
Measured at baseline/before intervention and after intervention (6 weeks after baseline)
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Anticipé)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2019/FO243016
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .